[
  {
    "title": "威尔药业(603351.SH)：高管王福秋、邹建国拟减持合计不超6.25万股",
    "href": "http://stock.jrj.com.cn/2022/12/14162237212077.shtml",
    "datetime": "2022-12-14 16:22:48",
    "code": "603351"
  },
  {
    "title": "威尔药业披露2022年半年报 实现营收5.88亿元",
    "href": "http://stock.jrj.com.cn/2022/08/22180136922297.shtml",
    "datetime": "2022-08-22 18:01:46",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)半年度净利润6076.24万元、同比增长7.55%",
    "href": "http://stock.jrj.com.cn/2022/08/22165336921814.shtml",
    "datetime": "2022-08-22 16:53:08",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：192.468万股限制性股票将解锁上市流通",
    "href": "http://stock.jrj.com.cn/2022/08/08160436878995.shtml",
    "datetime": "2022-08-08 16:04:36",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：“20000t/a注射用药用辅料及普通药用辅料产业基地项目”的剩余装置亦将进入试生产",
    "href": "http://stock.jrj.com.cn/2022/06/08153636712327.shtml",
    "datetime": "2022-06-08 15:36:56",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)2021年度权益分派10派3元 股权登记日为6月10日",
    "href": "http://stock.jrj.com.cn/2022/06/06180536706406.shtml",
    "datetime": "2022-06-06 18:05:23",
    "code": "603351"
  },
  {
    "title": "威尔药业股东唐群松质押284.5万股 用于个人资金需求",
    "href": "http://stock.jrj.com.cn/2022/06/01185036697805.shtml",
    "datetime": "2022-06-01 18:50:48",
    "code": "603351"
  },
  {
    "title": "威尔药业2022年第一季度净利2752.97万同比增长5.04% 销售量增加",
    "href": "http://stock.jrj.com.cn/2022/05/04121136554834.shtml",
    "datetime": "2022-05-04 12:11:38",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)一季度净利润2752.97万元 同比增长5.04%",
    "href": "http://stock.jrj.com.cn/2022/04/26155636475673.shtml",
    "datetime": "2022-04-26 15:56:35",
    "code": "603351"
  },
  {
    "title": "威尔药业2021年净利1.01亿同比增长0.92% 董事长吴仁荣薪酬121.39万",
    "href": "http://stock.jrj.com.cn/2022/04/18213236387645.shtml",
    "datetime": "2022-04-18 21:32:15",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：2021年净利增0.92%至1.01亿元 拟10派3元",
    "href": "http://stock.jrj.com.cn/2022/04/18174136386005.shtml",
    "datetime": "2022-04-18 17:41:49",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：子公司获得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2022/04/15154936344302.shtml",
    "datetime": "2022-04-15 15:49:29",
    "code": "603351"
  },
  {
    "title": "【龙虎榜】威尔药业3月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/22180834861500.shtml",
    "datetime": "2022-03-22 18:08:51",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：7100.09万股首发限售股2月7日上市流通",
    "href": "http://stock.jrj.com.cn/2022/01/21161834182629.shtml",
    "datetime": "2022-01-21 16:18:15",
    "code": "603351"
  },
  {
    "title": "威尔药业2名股东合计减持97.47万股 套现合计3042.65万 第三季度公司净利2734.34万",
    "href": "http://stock.jrj.com.cn/2022/01/10191034142426.shtml",
    "datetime": "2022-01-10 19:10:33",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：减持期届满 股东及监事已合计减持97.47万股",
    "href": "http://stock.jrj.com.cn/2022/01/10164434141520.shtml",
    "datetime": "2022-01-10 16:44:22",
    "code": "603351"
  },
  {
    "title": "【龙虎榜】威尔药业11月26日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/26180633924376.shtml",
    "datetime": "2021-11-26 18:06:43",
    "code": "603351"
  },
  {
    "title": "【龙虎榜】威尔药业11月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/25180633919662.shtml",
    "datetime": "2021-11-25 18:06:13",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：股东沈九四持股比例由6.4607%减至5.4607%",
    "href": "http://stock.jrj.com.cn/2021/11/04162433812965.shtml",
    "datetime": "2021-11-04 16:24:55",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)第三季度净利润2734.34万元 同比增长50.62%",
    "href": "http://stock.jrj.com.cn/2021/10/28193433771464.shtml",
    "datetime": "2021-10-28 19:34:57",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：拟出资2550万元共设南京兴威生物技术有限公司",
    "href": "http://stock.jrj.com.cn/2021/10/11180333674073.shtml",
    "datetime": "2021-10-11 18:03:29",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：减持期过半 沈九四及吴荣文累计减持63.53万股",
    "href": "http://stock.jrj.com.cn/2021/10/11175933674000.shtml",
    "datetime": "2021-10-11 17:59:38",
    "code": "603351"
  },
  {
    "title": "【龙虎榜】威尔药业9月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/09/13180733429261.shtml",
    "datetime": "2021-09-13 18:07:32",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)风险提示：募投项目未来可能存在产能利用率不足等风险",
    "href": "http://stock.jrj.com.cn/2021/09/10212433417127.shtml",
    "datetime": "2021-09-10 21:24:35",
    "code": "603351"
  },
  {
    "title": "【龙虎榜】威尔药业9月9日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/09/09180733410498.shtml",
    "datetime": "2021-09-09 18:07:01",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：“20000t/a注射用药用辅料及普通药用辅料产业基地项目”的部分装置进入试生产阶段",
    "href": "http://stock.jrj.com.cn/2021/09/06154733392219.shtml",
    "datetime": "2021-09-06 15:47:09",
    "code": "603351"
  },
  {
    "title": "威尔药业2021年上半年净利5649.8万下滑1.66% 原材料价格上涨",
    "href": "http://stock.jrj.com.cn/2021/07/29194333170845.shtml",
    "datetime": "2021-07-29 19:43:52",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)上半年净利降1.66%至5649.80万元",
    "href": "http://stock.jrj.com.cn/2021/07/29172333170159.shtml",
    "datetime": "2021-07-29 17:23:11",
    "code": "603351"
  },
  {
    "title": "威尔药业：公司暂无注入上市计划",
    "href": "http://stock.jrj.com.cn/2021/06/21170832970148.shtml",
    "datetime": "2021-06-21 17:08:14",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：沈九四及吴荣文拟合计减持不超214.2万股",
    "href": "http://stock.jrj.com.cn/2021/06/16160332940819.shtml",
    "datetime": "2021-06-16 16:03:28",
    "code": "603351"
  },
  {
    "title": "威尔药业：向2021年限制性股票激励计划激励对象授予限制性股票",
    "href": "http://stock.jrj.com.cn/2021/05/28060432832823.shtml",
    "datetime": "2021-05-28 06:04:29",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：向51名激励对象授予限制性股票共计487.32万股",
    "href": "http://stock.jrj.com.cn/2021/05/27173832830703.shtml",
    "datetime": "2021-05-27 17:38:49",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：2020年度拟10派3元 5月24日股权登记",
    "href": "http://stock.jrj.com.cn/2021/05/18190132777425.shtml",
    "datetime": "2021-05-18 19:01:44",
    "code": "603351"
  },
  {
    "title": "威尔药业2020年净利减少21.59% 董事长吴仁荣薪酬85.28万",
    "href": "http://stock.jrj.com.cn/2021/04/13155532364994.shtml",
    "datetime": "2021-04-13 15:55:33",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：2020年度净利降21.59%至1亿元 拟10派3元",
    "href": "http://stock.jrj.com.cn/2021/04/12195632359152.shtml",
    "datetime": "2021-04-12 19:56:00",
    "code": "603351"
  },
  {
    "title": "威尔药业：公司主营业务为药用辅料及合成润滑基础油产品的研发、生产和销售",
    "href": "http://stock.jrj.com.cn/2021/03/24145732208302.shtml",
    "datetime": "2021-03-24 14:57:54",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)拟推2021年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/03/10192132105065.shtml",
    "datetime": "2021-03-10 19:21:03",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)拟向银行申请不超6亿元综合授信额度",
    "href": "http://stock.jrj.com.cn/2021/01/19160431722036.shtml",
    "datetime": "2021-01-19 16:04:31",
    "code": "603351"
  },
  {
    "title": "威尔药业：公司在汽车及新能源车上的应用主要为空调系统中用油",
    "href": "http://stock.jrj.com.cn/2021/01/14095031689116.shtml",
    "datetime": "2021-01-14 09:50:29",
    "code": "603351"
  },
  {
    "title": "威尔药业：公司本次募投项目的实施可以扩大现有药用辅料品种产能及新增新品种的产能",
    "href": "http://stock.jrj.com.cn/2021/01/14095031689117.shtml",
    "datetime": "2021-01-14 09:50:15",
    "code": "603351"
  },
  {
    "title": "威尔药业：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/24001031119697.shtml",
    "datetime": "2020-10-24 00:10:29",
    "code": "603351"
  },
  {
    "title": "威尔药业：第二届董事会第六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/24001031119696.shtml",
    "datetime": "2020-10-24 00:10:28",
    "code": "603351"
  },
  {
    "title": "威尔药业前三季度净利7560.3万下滑31.5% 管理费用同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/23202231118700.shtml",
    "datetime": "2020-10-23 20:22:41",
    "code": "603351"
  },
  {
    "title": "威尔药业：2020年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/15001031054815.shtml",
    "datetime": "2020-10-15 00:10:29",
    "code": "603351"
  },
  {
    "title": "威尔药业控股股东及一致行动人合计质押3539万股 用于自身资金需求",
    "href": "http://stock.jrj.com.cn/2020/09/11193530732006.shtml",
    "datetime": "2020-09-11 19:35:43",
    "code": "603351"
  },
  {
    "title": "威尔药业(603351.SH)：控股股东及一 致行动人等合计质押3539万股",
    "href": "http://stock.jrj.com.cn/2020/09/11181630731658.shtml",
    "datetime": "2020-09-11 18:16:15",
    "code": "603351"
  },
  {
    "title": "威尔药业2020年上半年净利5744.97万下滑24.91% 销售量下降",
    "href": "http://stock.jrj.com.cn/2020/08/19222130541596.shtml",
    "datetime": "2020-08-19 22:21:24",
    "code": "603351"
  },
  {
    "title": "威尔药业：公司合成润滑基础油未直接供应给上海特斯拉生产基地",
    "href": "http://stock.jrj.com.cn/2020/08/14104130497634.shtml",
    "datetime": "2020-08-14 10:41:51",
    "code": "603351"
  },
  {
    "title": "[威尔药业]重产品学习 强销售队伍",
    "href": "http://stock.jrj.com.cn/2020/08/11000030474130.shtml",
    "datetime": "2020-08-11 00:00:00",
    "code": "603351"
  },
  {
    "title": "[威尔药业]生产、科研专场招聘会成功举行——2020年度东南大学成贤学院校招会",
    "href": "http://stock.jrj.com.cn/2020/08/10000030469188.shtml",
    "datetime": "2020-08-10 00:00:00",
    "code": "603351"
  },
  {
    "title": "威尔药业股东沈九四减持126万股 套现约2990.06万元",
    "href": "http://stock.jrj.com.cn/2020/08/03203930415220.shtml",
    "datetime": "2020-08-03 20:39:02",
    "code": "603351"
  },
  {
    "title": "[威尔药业]奋斗的2020“二次创业 再出发”",
    "href": "http://stock.jrj.com.cn/2020/07/31000030469189.shtml",
    "datetime": "2020-07-31 00:00:00",
    "code": "603351"
  },
  {
    "title": "【龙虎榜】威尔药业7月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/29180630374769.shtml",
    "datetime": "2020-07-29 18:06:50",
    "code": "603351"
  },
  {
    "title": "【龙虎榜】威尔药业7月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/24181030334825.shtml",
    "datetime": "2020-07-24 18:10:03",
    "code": "603351"
  },
  {
    "title": "威尔药业：生产装置开始全面停车检修 预计达48天左右",
    "href": "http://stock.jrj.com.cn/2020/07/20181630294582.shtml",
    "datetime": "2020-07-20 18:16:34",
    "code": "603351"
  },
  {
    "title": "快讯：威尔药业急速拉升6.87% 主力资金净流入1036.23万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/03094430130640.shtml",
    "datetime": "2020-07-03 09:44:31",
    "code": "603351"
  },
  {
    "title": "[威尔药业]“6.5环境日及安全生产月”主题活动",
    "href": "http://stock.jrj.com.cn/2020/06/23000030474134.shtml",
    "datetime": "2020-06-23 00:00:00",
    "code": "603351"
  },
  {
    "title": "[威尔药业]整合型管理体系---未来认证发展的方向",
    "href": "http://stock.jrj.com.cn/2020/06/15000030474129.shtml",
    "datetime": "2020-06-15 00:00:00",
    "code": "603351"
  },
  {
    "title": "威尔药业股东唐群松质押280万股 用于个人资金需求",
    "href": "http://stock.jrj.com.cn/2020/06/02190929829072.shtml",
    "datetime": "2020-06-02 19:09:42",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/05/21002029725168.shtml",
    "datetime": "2020-05-21 00:20:02",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/12232029653903.shtml",
    "datetime": "2020-05-12 23:20:04",
    "code": "603351"
  },
  {
    "title": "威尔药业第一季度盈利3218.65万 较上年同期减少15.67%",
    "href": "http://stock.jrj.com.cn/2020/05/01220029441526.shtml",
    "datetime": "2020-05-01 22:00:57",
    "code": "603351"
  },
  {
    "title": "威尔药业：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405386.shtml",
    "datetime": "2020-04-28 15:50:28",
    "code": "603351"
  },
  {
    "title": "威尔药业：关于公司更名及完成工商变更登记的公告",
    "href": "http://stock.jrj.com.cn/2020/04/24004029361812.shtml",
    "datetime": "2020-04-24 00:40:07",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/21012029332632.shtml",
    "datetime": "2020-04-21 01:20:05",
    "code": "603351"
  },
  {
    "title": "威尔药业：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/21012029332634.shtml",
    "datetime": "2020-04-21 01:20:05",
    "code": "603351"
  },
  {
    "title": "威尔药业：第二届董事会第二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/21012029332633.shtml",
    "datetime": "2020-04-21 01:20:05",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年净利同比增15% 拟10转4派4.5元",
    "href": "http://stock.jrj.com.cn/2020/04/20202829331370.shtml",
    "datetime": "2020-04-20 20:28:00",
    "code": "603351"
  },
  {
    "title": "威尔药业：第二届董事会第一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/08231029240201.shtml",
    "datetime": "2020-04-08 23:10:26",
    "code": "603351"
  },
  {
    "title": "威尔药业：2020年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/08231029240200.shtml",
    "datetime": "2020-04-08 23:10:25",
    "code": "603351"
  },
  {
    "title": "威尔药业：关于召开2020年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/03/12011029004120.shtml",
    "datetime": "2020-03-12 01:10:32",
    "code": "603351"
  },
  {
    "title": "威尔药业：第一届董事会第十八次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/12011029004119.shtml",
    "datetime": "2020-03-12 01:10:31",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年净利1.29亿元 同比增长15%",
    "href": "http://stock.jrj.com.cn/2020/03/09163028980948.shtml",
    "datetime": "2020-03-09 16:30:55",
    "code": "603351"
  },
  {
    "title": "威尔药业业绩快报：2019年净利同比增长15.48％",
    "href": "http://stock.jrj.com.cn/2020/03/09161628980844.shtml",
    "datetime": "2020-03-09 16:16:44",
    "code": "603351"
  },
  {
    "title": "威尔药业业绩快报：2019年净利1.29亿元 同比增15%",
    "href": "http://stock.jrj.com.cn/2020/03/09161528980834.shtml",
    "datetime": "2020-03-09 16:15:00",
    "code": "603351"
  },
  {
    "title": "威尔药业股东及监事计划减持公司股份 合计预计减持不超过150万股",
    "href": "http://stock.jrj.com.cn/2020/02/05210428778182.shtml",
    "datetime": "2020-02-05 21:04:50",
    "code": "603351"
  },
  {
    "title": "威尔药业：股东及监事拟合计减持不超1.6%股份",
    "href": "http://stock.jrj.com.cn/2020/02/05160428776589.shtml",
    "datetime": "2020-02-05 16:04:00",
    "code": "603351"
  },
  {
    "title": "威尔药业：股东拟联合减持不超过公司股份的1.6%",
    "href": "http://stock.jrj.com.cn/2020/02/05155628776543.shtml",
    "datetime": "2020-02-05 15:56:52",
    "code": "603351"
  },
  {
    "title": "威尔药业：关于首次公开发行限售股上市流通的公告",
    "href": "http://stock.jrj.com.cn/2020/01/17231028695378.shtml",
    "datetime": "2020-01-17 23:10:06",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/11/16024028407062.shtml",
    "datetime": "2019-11-16 02:40:01",
    "code": "603351"
  },
  {
    "title": "威尔药业前三季度盈利1.1亿 同比增长31%",
    "href": "http://stock.jrj.com.cn/2019/10/29085028315716.shtml",
    "datetime": "2019-10-29 08:50:17",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/29001028313536.shtml",
    "datetime": "2019-10-29 00:10:08",
    "code": "603351"
  },
  {
    "title": "威尔药业：第一届董事会第十七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/10/29001028313537.shtml",
    "datetime": "2019-10-29 00:10:08",
    "code": "603351"
  },
  {
    "title": "威尔药业：关于召开2019年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/10/29001028313538.shtml",
    "datetime": "2019-10-29 00:10:08",
    "code": "603351"
  },
  {
    "title": "[威尔药业]无偿献血 无尚光荣 ———威尔药业7·24献血活动报道",
    "href": "http://stock.jrj.com.cn/2019/10/09000028217734.shtml",
    "datetime": "2019-10-09 00:00:00",
    "code": "603351"
  },
  {
    "title": "威尔药业使用部分闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2019/08/20095528003760.shtml",
    "datetime": "2019-08-20 09:55:14",
    "code": "603351"
  },
  {
    "title": "威尔药业：第一届董事会第十六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/19231027998531.shtml",
    "datetime": "2019-08-19 23:10:17",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/19231027998506.shtml",
    "datetime": "2019-08-19 23:10:15",
    "code": "603351"
  },
  {
    "title": "威尔药业2019年上半年销售收入4.21亿元",
    "href": "http://stock.jrj.com.cn/2019/08/19195727998929.shtml",
    "datetime": "2019-08-19 19:57:03",
    "code": "603351"
  },
  {
    "title": "威尔药业董事长吴仁荣：并购要围绕产业升级",
    "href": "http://stock.jrj.com.cn/2019/06/25154327753115.shtml",
    "datetime": "2019-06-25 15:43:00",
    "code": "603351"
  },
  {
    "title": "威尔药业：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/05/21222027603264.shtml",
    "datetime": "2019-05-21 22:20:04",
    "code": "603351"
  },
  {
    "title": "威尔药业：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/05/11005027555942.shtml",
    "datetime": "2019-05-11 00:50:01",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/25075027478957.shtml",
    "datetime": "2019-04-25 07:50:17",
    "code": "603351"
  },
  {
    "title": "威尔药业：第一届董事会第十五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/25075027478958.shtml",
    "datetime": "2019-04-25 07:50:17",
    "code": "603351"
  },
  {
    "title": "威尔药业：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/16222027409211.shtml",
    "datetime": "2019-04-16 22:20:03",
    "code": "603351"
  },
  {
    "title": "威尔药业：第一届董事会第十四次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/16222027409212.shtml",
    "datetime": "2019-04-16 22:20:03",
    "code": "603351"
  },
  {
    "title": "威尔药业：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/16222027409213.shtml",
    "datetime": "2019-04-16 22:20:03",
    "code": "603351"
  },
  {
    "title": "威尔药业：2018年净利同比增长4% 拟10转4派6元",
    "href": "http://stock.jrj.com.cn/2019/04/16202927408614.shtml",
    "datetime": "2019-04-16 20:29:01",
    "code": "603351"
  },
  {
    "title": "威尔药业：2018年净利同比增4% 拟10转4派6元",
    "href": "http://stock.jrj.com.cn/2019/04/16195827408546.shtml",
    "datetime": "2019-04-16 19:58:00",
    "code": "603351"
  },
  {
    "title": "威尔药业2018年净利增长4% 拟10转4派6元",
    "href": "http://stock.jrj.com.cn/2019/04/16193627408391.shtml",
    "datetime": "2019-04-16 19:36:00",
    "code": "603351"
  },
  {
    "title": "威尔药业：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/03/26225027244339.shtml",
    "datetime": "2019-03-26 22:50:06",
    "code": "603351"
  },
  {
    "title": "威尔药业首次打开一字涨停 累计上涨71.92%",
    "href": "http://stock.jrj.com.cn/2019/02/11163527028613.shtml",
    "datetime": "2019-02-11 16:35:59",
    "code": "603351"
  },
  {
    "title": "威尔药业现熊股相：客户疑似关联方 财务风险遭诟病",
    "href": "http://stock.jrj.com.cn/2019/02/11124627027898.shtml",
    "datetime": "2019-02-11 12:46:25",
    "code": "603351"
  },
  {
    "title": "威尔药业1月30日上市定位分析",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/29133326996616.shtml",
    "datetime": "2019-01-29 13:33:27",
    "code": "603351"
  },
  {
    "title": "威尔药业逾7.4万股遭投资者放弃认购",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/21200526937273.shtml",
    "datetime": "2019-01-21 20:05:45",
    "code": "603351"
  },
  {
    "title": "【兑奖啦】新乳业、威尔药业网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/2019/01/17202026920505.shtml",
    "datetime": "2019-01-17 20:20:21",
    "code": "603351"
  },
  {
    "title": "【兑奖啦】威尔药业网上申购中签号出炉 共16666个",
    "href": "http://stock.jrj.com.cn/2019/01/17195026920355.shtml",
    "datetime": "2019-01-17 19:50:00",
    "code": "603351"
  },
  {
    "title": "新乳业、威尔药业中签率公布 明日公布中签结果",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/16211726915391.shtml",
    "datetime": "2019-01-16 21:17:17",
    "code": "603351"
  },
  {
    "title": "威尔药业：网上定价发行中签率为0.01832263％",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/16200726915130.shtml",
    "datetime": "2019-01-16 20:07:50",
    "code": "603351"
  },
  {
    "title": "威尔药业、新乳业1月16日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2019/01/15145626906991.shtml",
    "datetime": "2019-01-15 14:56:55",
    "code": "603351"
  },
  {
    "title": "威尔药业IPO数据谜团待解 1.68吨产品销量去向何处？",
    "href": "http://stock.jrj.com.cn/2018/09/20154625120494.shtml",
    "datetime": "2018-09-20 15:46:33",
    "code": "603351"
  },
  {
    "title": "威尔药业IPO过会：新增股东与保荐机构中信建投关系引问询",
    "href": "http://stock.jrj.com.cn/ipo/2018/08/22101925098525.shtml",
    "datetime": "2018-08-22 10:19:00",
    "code": "603351"
  },
  {
    "title": "威尔药业IPO过会：新增股东与保荐机构中信建投关系引问询",
    "href": "http://stock.jrj.com.cn/ipo/2018/08/22101924984987.shtml",
    "datetime": "2018-08-22 10:19:00",
    "code": "603351"
  },
  {
    "title": "威尔药业IPO过会：新增股东与保荐机构中信建投关系引问询",
    "href": "http://stock.jrj.com.cn/ipo/2018/08/22101925328656.shtml",
    "datetime": "2018-08-22 10:19:00",
    "code": "603351"
  },
  {
    "title": "南京威尔药业首发过会",
    "href": "http://stock.jrj.com.cn/2018/08/21165524981792.shtml",
    "datetime": "2018-08-21 16:55:00",
    "code": "603351"
  },
  {
    "title": "南京威尔药业股份有限公司首次公开发行股票招股说明书（申报稿2018年4月18日报送）",
    "href": "http://stock.jrj.com.cn/ipo/2018/04/27210424467612.shtml",
    "datetime": "2018-04-27 21:04:35",
    "code": "603351"
  },
  {
    "title": "[威尔药业]南京威尔药业股份有限公司2017年年会圆满成功",
    "href": "http://stock.jrj.com.cn/2018/03/19000026899688.shtml",
    "datetime": "2018-03-19 00:00:00",
    "code": "603351"
  },
  {
    "title": "威尔药业IPO：应收账款周转率下滑 子公司曾遭环保处罚",
    "href": "http://stock.jrj.com.cn/ipo/2017/11/29091523711544.shtml",
    "datetime": "2017-11-29 09:15:00",
    "code": "603351"
  },
  {
    "title": "[威尔药业]南京威尔庆3.8女神节专题报道",
    "href": "http://stock.jrj.com.cn/2017/09/30000026899689.shtml",
    "datetime": "2017-09-30 00:00:00",
    "code": "603351"
  }
]